Clinical Trial Update: Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects [Phase 3]

View source ↗

Summary

Phase 3 study comparing darunavir/ritonavir plus tenofovir/emtricitabine versus darunavir/ritonavir plus raltegravir in antiretroviral-naïve HIV-infected adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)
• tenofovir disoproxil fumarate/emtricitabine (tenofovir disoproxil fumarate/emtricitabine)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infections | Phase 3 | Status: COMPLETED